SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vital Therapies, Inc.

Aug 27, 2015, 10:00 ET from Bronstein, Gewirtz & Grossman, LLC

NEW YORK, Aug. 27, 2015 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Vital Therapies, Inc.("Vital Therapies" or the "Company") (NasdaqGS: VTL -News).  Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.

The investigation concerns whether Vital Therapies and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On July 14, 2015, an analyst report published in Seeking Alpha alleged that the Company misled investors regarding the ELAD systems patients' overall survival rate, as Vital included survival data from a patient who received a liver transplant, while no equivalent patient in the control group had received a transplant. This fact was not disclosed in any of the company's prior disclosures. On this news, Vital shares fell $3.61 per share, or 14%, to close on July 15, 2015 at $23.10. On August 21, 2015, the Company announced topline results from its ELAD systems VTI-208 study, and reported that the study, "failed to achieve primary or secondary endpoints of improvement in overall survival."

Following this news, the shares of Vital fell $14.03 per share, or over 79%, on August 24, 2015.

If you are aware of any facts relating to this investigation, or purchased shares of Vital Therapies, you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com.  Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Eitan Kimelman 212-697-6484 info@bgandg.com

SOURCE Bronstein, Gewirtz & Grossman, LLC



RELATED LINKS

http://www.bgandg.com